Announcements Trials
Browse Landscape

Phase

Phase 1 1

Status

Recruiting 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Other solid neoplasm 1

Conditions

Colorectal Neoplasms 24Stomach Neoplasms 5Rectal Neoplasms 5Neoplasm Metastasis 5Colonic Neoplasms 5Carcinoma, Hepatocellular 4Cholangiocarcinoma 3Biliary Tract Neoplasms 3Adenocarcinoma Of Esophagus 3Unresectable Metastatic Colorectal Cancer 2Recurrence 2Neoplastic Cells, Circulating 2Neoplasms 2Gastrointestinal Neoplasms 2Carcinoma, Non-Small-Cell Lung 2Adenocarcinoma 2Squamous Cell Carcinoma of Head and Neck 1Solid Tumors 1Ovarian Neoplasms 1Oligometastatic Gastric Adenocarcinoma 1Neoplasms, Second Primary 1Neoplasm, Residual 1Margins of Excision 1Lung Neoplasms 1Locally-advanced Rectal Cancer 1Locally Advanced Colorectal Carcinoma 1Hyperthermia 1Gastroesophageal Junction Adenocarcinoma 1Gastroesophageal Adenocarcinoma 1Gallbladder Neoplasms 1

Interventions

Injections 16pembrolizumab 6Bevacizumab 6Paclitaxel 4Leucovorin 4Fluorouracil 4Carboplatin 4fludarabine 3Pemetrexed 3Oxaliplatin 3Capecitabine 3toripalimab 2sotorasib 2Immune Checkpoint Inhibitors 2Fulvestrant 2Drug Therapy 2Docetaxel 2Cyclophosphamide 2Cisplatin 2130-nm albumin-bound paclitaxel 2zimberelimab 1trifluridine tipiracil drug combination 1trametinib 1tislelizumab 1sacituzumab govitecan 1palbociclib 1osimertinib 1olaparib 1lazertinib 1fluzoparib 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Recruiting × Advanced Solid Tumors × Folfox protocol × Clear all
NCT06719362 2025-07-10

A Clinical Trial to Evaluate the Safety, Tolerability and Clinical Efficacy of M3T01 Monotherapy and in Combination With Pembrolizumab and Other Systemic Therapies

Providence Health & Services

Phase 1 Recruiting
110 enrolled
Other solid neoplasm

Advanced Solid Tumors

Data powered by HemOnc (CC BY 4.0) Colophon âš¡